Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Summit Insights Group Downgrades NVIDIA to Sell

Summit Insights Group analyst Kinngai Chan downgrades NVIDIA (NASDAQ:NVDA) from Hold to Sell.

byBenzinga Newsdesk

August 19, 2021

1 minute read

Summit Insights Group analyst Kinngai Chan downgrades NVIDIA (NASDAQ:NVDA) from Hold to Sell.

Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket

By Lisa Levin

Today, 3:14 AM

Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an average price of $2.03 - $2.07.

ACRX

CNBC Halftime Report Final Trades: Berkshire Hathaway B, Adobe & Alaska Air Group

By Benzinga Newsdesk

Today, 3:14 AM

- CNBC

ADBE

The Hackett Group Q2 EPS $0.39 Beats $0.29 Estimate, Sales $73.00M Beat $65.28M Estimate

By Benzinga Newsdesk

Today, 3:14 AM

The Hackett Group (NASDAQ:HCKT) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.29 by 34.48 percent. This is a 550 percent increase over earnings of $0.06 per share from the

HCKT

Oragenics Announces Posting Of PRepring Manuscript On Data For Intranasal SARS-CoV-2 Vaccine Candidate

By Bill Haddad

Today, 3:14 AM

Intranasal Immunization Lowers the Viral Load Below the Limit of Detection in Lungs of Hamsters Oragenics, Inc. (NYSE:OGEN) ("Oragenics" or the "Company") today announced the posting of a

OGEN

Summit Insights Group Downgrades NVIDIA to Sell

Related Posts

Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket

CNBC Halftime Report Final Trades: Berkshire Hathaway B, Adobe & Alaska Air Group

The Hackett Group Q2 EPS $0.39 Beats $0.29 Estimate, Sales $73.00M Beat $65.28M Estimate

Oragenics Announces Posting Of PRepring Manuscript On Data For Intranasal SARS-CoV-2 Vaccine Candidate